迷幻药物检查:对经典迷幻药物减害的分析和战略挑战
Tim Hirschfeld1,2, Felix Blei3, Lavinia Stegemann4
1Charité - Universitätsmedizin Berlin, corporate member of Freie Universität, Humbold-Universität zu Berlin, and Berlin Institute of Health, Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany. tim.hirschfeld@charite.de.
对使用LSD和psilocybin等经典迷幻药的用户来说,药物检查至关重要. 它通过使用分析技术和明确的风险沟通来帮助最大限度地减少未知物质的危害.
科学领域:
- 精神活性物质分析 精神活性物质分析
- 公共卫生干预措施 公共卫生干预措施
- 减少危害的策略
背景情况:
- 不受监管的经典迷幻药物 (LSD,psilocybin,DMT) 由于未知的染剂和功效带来风险.
- 药物检查服务对于减轻这些物质使用者的伤害至关重要.
- 现有的分析方法和干预设置既有机遇又有挑战.
研究的目的:
- 探索药物检查对经典迷幻药品使用者的重要性.
- 检查用于识别迷幻物质的分析技术.
- 评估药物检查中的风险沟通策略和干预设置.
主要方法:
- 使用气体染色学-质谱学 (GC-MS) 和液体染色学-质谱学 (LC-MS) 进行可靠的分析.
- 采用假设性测试,如薄层染色学 (TLC) 和试剂测试,以进行经济高效的查.
- 纳入福里埃变换红外光谱法 (FTIR) 作为一种补充技术,承认其局限性.
主要成果:
- 虽然GC-MS和LC-MS提供了全面但昂贵的静止分析.
- TLC和试剂测试提供了高效的初始选.
- 对于某些化合物和矩阵,FTIR可能受到检测极限的限制,因此需要多种分析方法.
- 结合方法可以加强急性风险预防,而仪器分析是公共卫生监测的关键.
结论:
- 药物检查,将强有力的测试与咨询相结合,是一个关键的公共卫生措施.
- 它有效地减少了被误导的迷幻物质造成的急性伤害.
- 它有助于监测危险或新型物质,并为公共卫生工作提供信息.
更多相关视频
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
11:14Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
Published on: October 2, 2016
相关概念视频
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
CNS Stimulants: Psychedelic Agents
Drug Control Governance: Regulatory Bodies and Their Impact
An Overview of Psychoactive Drugs
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
